Back to top
more

Delcath Systems (DCTH)

(Delayed Data from NSDQ)

$4.48 USD

4.48
200,583

-0.26 (-5.39%)

Updated Apr 17, 2024 04:00 PM ET

After-Market: $4.47 -0.01 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Can Delcath Systems (DCTH) Climb 277.73% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 277.7% upside potential for Delcath Systems (DCTH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Delcath Systems (DCTH) Upgraded to Buy: What Does It Mean for the Stock?

Delcath Systems (DCTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Delcath Systems, Inc. (DCTH) Reports Q4 Loss, Tops Revenue Estimates

Delcath Systems (DCTH) delivered earnings and revenue surprises of 28.36% and 12.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

DexCom (DXCM) Soars 9.8%: Is Further Upside Left in the Stock?

DexCom (DXCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of -11.11% and 0.10%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 12.12% and 16.74%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Inari Medical, Inc. (NARI) Tops Q2 Earnings and Revenue Estimates

Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 128.57% and 2.34%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Intuitive Surgical, Inc. (ISRG) Tops Q2 Earnings and Revenue Estimates

Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 7.58% and 1.35%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Dynatronics Corporation (DYNT) Reports Q3 Loss, Misses Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of -125% and 11.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates

Orthofix (OFIX) delivered earnings and revenue surprises of 50% and 3.79%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical (GMED) Surpasses Q1 Earnings and Revenue Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of 3.92% and 8.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of -2.63% and 1.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Delcath Systems, Inc. (DCTH) Reports Q3 Loss, Tops Revenue Estimates

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of 12.38% and 10.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Tops Q3 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of 5.56% and 1.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Semler Scientific Inc. (SMLR) Q3 Earnings Beat Estimates

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 24.32% and 6.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Acadia Healthcare (ACHC) Q3 Earnings Lag Estimates

Acadia Healthcare (ACHC) delivered earnings and revenue surprises of -2.50% and 1.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Delcath Systems, Inc. (DCTH) Reports Q2 Loss, Lags Revenue Estimates

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of -34.09% and 36.49%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

DexCom (DXCM) Matches Q2 Earnings Estimates

DexCom (DXCM) delivered earnings and revenue surprises of 0% and 0.12%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of -19.05% and 70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates

Orthofix (OFIX) delivered earnings and revenue surprises of -155.56% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of -15.63% and 1.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Delcath Systems, Inc. (DCTH) Reports Q4 Loss, Tops Revenue Estimates

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of 25.81% and 285.38%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Sientra (SIEN) Reports Q4 Loss, Tops Revenue Estimates

Sientra (SIEN) delivered earnings and revenue surprises of -42.11% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Delcath Systems, Inc. (DCTH) Reports Q3 Loss, Misses Revenue Estimates

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of -3.30% and -9.22%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Delcath Systems, Inc. (DCTH) Stock Jumps 6.6%: Will It Continue to Soar?

Delcath Systems, Inc. (DCTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.